Beth Hennessey
About Beth Hennessey
Beth Hennessey is the Senior Safety Trial Operations Manager for Interventional Cardiology at Boston Scientific, overseeing approximately 25 clinical trials and managing a $70 million budget in 2016.
Company
Beth Hennessey is currently working at Boston Scientific, a global leader in medical device manufacturing. Boston Scientific is renowned for its innovations in medical technology, particularly in the field of Interventional Cardiology. Beth has been part of the Boston Scientific team in various capacities, demonstrating her extensive experience and deep knowledge of the company's operations and strategic initiatives.
Title
Beth Hennessey holds the title of Senior Safety Trial Operations Manager, Interventional Cardiology. In this role, she is responsible for overseeing the safety of approximately 25 clinical trials in the Interventional Cardiology division. Her responsibilities also include managing budgets and leading key corporate initiatives across Boston Scientific's Clinical and Medical organizations.
Education and Expertise
Beth Hennessey earned her Bachelor of Arts (BA) in Biology, General, from the College of the Holy Cross from 2000 to 2004. She furthered her education with an MBA focused on Health Care Concentration from Clark University, completed between 2006 and 2009. Her educational background has provided her with a strong foundation in biology and healthcare management, which she has effectively applied in her professional roles.
Background
Beth Hennessey has a long-standing career at Boston Scientific, starting as a Senior Medical Research Associate from 2006 to 2009. She then held positions as a Safety Trial Manager, Safety Line Manager, and IC Safety Trial Operations Manager before securing her current role. Her progression within the company highlights her expertise in clinical trial management and safety oversight.
Achievements
Beth has managed clinical trials with a budget of $70 million for the year 2016 and played a key role in optimizing CRO partnerships to meet contract metric targets. She has also contributed significantly to the development of efficient and cost-effective models for running small clinical studies and serves as a Subject Matter Expert on Quality Systems management. Her contributions include managing IC Clinical wide CAPAs and NCEPs, showcasing her role in maintaining high-quality standards and ensuring regulatory compliance.